Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Dralzine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 216Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Macleods Pharmaceutical`s Generics Hydralazine Hydrochloride Receives Approval in US
    Macleods Pharmaceutical`s Generics Hydralazine Hydrochloride Receives Approval in US

    21 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211010

    FDA
    21 Aug 2024
    Share Share
    Enforcement Report - Week of February 21, 2024
    Enforcement Report - Week of February 21, 2024

    21 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-21-2024-40984.pdf

    FDA
    21 Feb 2024
    Share Share
    Enforcement Report - Week of February 14, 2024
    Enforcement Report - Week of February 14, 2024

    14 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2024-75684.pdf

    FDA
    14 Feb 2024
    Share Share
    I3 Pharms` Generic Isosorbide Dinitrate & Hydralazine Hydrochloride Receives Approval in the U.S.
    I3 Pharms` Generic Isosorbide Dinitrate & Hydralazine Hydrochloride Receives Approval in the U.S.

    17 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215988

    FDA
    17 Jan 2024
    Share Share
    Enforcement Report - Week of October 11, 2023
    Enforcement Report - Week of October 11, 2023

    11 Oct 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-11-2023-46012.pdf

    FDA
    11 Oct 2023
    Share Share
    Upsher-Smith's Generic Hydralazine HCL Receives Receives Approval in the U.S.
    Upsher-Smith's Generic Hydralazine HCL Receives Receives Approval in the U.S.

    10 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083560

    FDA
    10 May 2023
    Share Share